Amgen (NASDAQ:AMGN) today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha ® ...
Q3 2025 Earnings Call November 6, 2025 8:00 AM ESTCompany ParticipantsAndrew Barnett - Head of Investor RelationsPascal Soriot - ...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention ...
As someone who easily overheats, I’m always looking for the next best product to help me manage sweat and odor. Whole body deodorant caught my interest, so I spoke with board-certified dermatologists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback